Abstract
Peptide arrays are useful tools to characterize antibodies, to determine sequence specificities of enzymes, or to find interaction partners to given peptide sequences. One widely-used format for such arrays is a cellulose sheet with hundreds of synthetic peptides bound to it. These SPOT arrays have been used successfully in a broad range of applications since their invention at the beginning of the nineties. The simplicity and robustness of this method along with the fully automated synthesis to generate custom arrays with high peptide densities made the SPOT method popular. A drawback of the SPOT method is the use of large reagent volumes and the limited throughput with only one copy of the library. CelluSpots represent a new method that retains the advantages of the SPOT method but allows the production of hundreds of identical copies on microscope slides for parallel screenings with low sample volumes.
Keywords: Antibody profiling, CelluSpots, kinase substrates, peptide arrays, peptide conjugates, protein interaction, SPOT
Mini-Reviews in Organic Chemistry
Title: CelluSpots Arrays as an Alternative to Peptide Arrays on Membrane Supports
Volume: 8 Issue: 2
Author(s): Daniel Maisch, Ian Schmitz and Ole Brandt
Affiliation:
Keywords: Antibody profiling, CelluSpots, kinase substrates, peptide arrays, peptide conjugates, protein interaction, SPOT
Abstract: Peptide arrays are useful tools to characterize antibodies, to determine sequence specificities of enzymes, or to find interaction partners to given peptide sequences. One widely-used format for such arrays is a cellulose sheet with hundreds of synthetic peptides bound to it. These SPOT arrays have been used successfully in a broad range of applications since their invention at the beginning of the nineties. The simplicity and robustness of this method along with the fully automated synthesis to generate custom arrays with high peptide densities made the SPOT method popular. A drawback of the SPOT method is the use of large reagent volumes and the limited throughput with only one copy of the library. CelluSpots represent a new method that retains the advantages of the SPOT method but allows the production of hundreds of identical copies on microscope slides for parallel screenings with low sample volumes.
Export Options
About this article
Cite this article as:
Maisch Daniel, Schmitz Ian and Brandt Ole, CelluSpots Arrays as an Alternative to Peptide Arrays on Membrane Supports, Mini-Reviews in Organic Chemistry 2011; 8 (2) . https://dx.doi.org/10.2174/157019311795177736
DOI https://dx.doi.org/10.2174/157019311795177736 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
Current Gene Therapy Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design Targeting the Lung: Preclinical and Comparative Evaluation of Anticancer Aerosols in Dogs with Naturally Occurring Cancers
Current Cancer Drug Targets MicroRNAs and Cancer: Towards a Personalized Medicine
Current Molecular Medicine Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Current Pharmaceutical Biotechnology Anticancer Activity and DNA Binding of 4-Alkylenediamines Modified Naphthalimide Derivatives
Letters in Drug Design & Discovery The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy
Current Medicinal Chemistry DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Current Medicinal Chemistry Translational Gap in Glioma Research
Anti-Cancer Agents in Medicinal Chemistry Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Anti-Cancer Agents in Medicinal Chemistry Distribution, Bioactivities and Therapeutical Potentials of Pentagalloylglucopyranose
Current Bioactive Compounds The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Luteolin Stimulates Proliferation and Inhibits Late Differentiation of Primary Rat Calvarial Osteoblast Induced by High-dose Dexamethasone via Sema3A /NRP1/Pleixin A1
Current Pharmaceutical Biotechnology The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Challenge of a “Functional Cure” for AIDS by Gene Modified HSCT Therapy
Current Stem Cell Research & Therapy Recent Advances in Cancer Therapy: An Overview
Current Pharmaceutical Design Histone Modifications as Molecular Targets in Nasopharyngeal Cancer
Current Medicinal Chemistry Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy
Current Pharmaceutical Design Evaluation of Brazilian Biotechnology Patent Activity from 1975 to 2010
Recent Patents on DNA & Gene Sequences